M. Michelle Berrey - Jun 14, 2021 Form 3 Insider Report for INTERCEPT PHARMACEUTICALS, INC. (ICPT)

Role
President, R&D and CMO
Signature
/s/ Mary J. Grendell, as attorney-in-fact
Stock symbol
ICPT
Transactions as of
Jun 14, 2021
Transactions value $
$0
Form type
3
Date filed
6/15/2021, 07:00 PM
Next filing
Jan 31, 2022

No securities are beneficially owned.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney